MDMA (designer drug)
Non-Contact Detection of Fentanyl and Other Opioids: Towards a Generalized Approach to Detection of Dangerous Drug Classes
Detecting Drug Exposure Long After the Fact: New Method Proves Effective
NIJ-funded researchers develop a novel blood protein modification assay to detect drug exposure long after the limits of traditional urine or blood tests.
Synthetic Stimulant Market Rapidly Changing as N,N-Dimethylpentylone Replaces Eutylone in Drug Supply Typically Sold as "Ecstasy" or "Molly"
LC-MS Screening Assay For Abused Drug Exposure Based On Covalent Peptide/Protein Modification
Taking Stock: An Overview of NIJ's Reentry Research Portfolio and Assessing the Impact of the Pandemic on Reentry Research
Over several decades, the National Institute of Justice (NIJ) has made significant contributions to the field of reentry, specifically what works for whom and when. In recent years, however, the global pandemic has made it increasingly difficult to conduct research on and with populations involved with the justice system. During this time, many researchers assessing various justice-related outcomes were unable to continue their inquiries as planned due to a lack of access to their populations of interest, forcing many to pivot and rethink their research designs.
See the YouTube Terms of Service and Google Privacy Policy